TSE:4568Pharmaceuticals
A Look At Daiichi Sankyo (TSE:4568) Valuation After DATROWAY Priority Review Milestone
Daiichi Sankyo Company (TSE:4568) shares are in focus after the U.S. FDA accepted and granted Priority Review to a supplemental Biologics License Application for DATROWAY in advanced triple negative breast cancer.
See our latest analysis for Daiichi Sankyo Company.
At a share price of ¥2,952.0, Daiichi Sankyo’s 1 day share price return of 2.89% and 7 day gain of 1.22% contrast with a 30 day share price decline of 16.66% and a 1 year total shareholder return of 19.19% in the red. This suggests...